ThromboGenics completes private placement

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Business: Cardiovascular, Ophthalmic Date completed: 12/3/10 Type: Private placement Raised: €55.9 million ($74.2 million) Shares: 2.9 million Price:...